phenyl thiohypochlorite | CAS:931-59-9

We serve phenyl thiohypochlorite CAS:931-59-9 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
phenyl thiohypochlorite

Synonyms:
Benzenesulfenyl chloride
Phenyl-sulfoniumylidene Chloride
thiohypochlorous acid phenyl ester
Phenylsulfenylchloride
 
Molecular Formula: C6H5ClS
Molecular Weight: 144.62200

Appearance and properties: purple-red hygroscopic oily liquid
Density: 1.25 g/cm3
Boiling point: 261.7ºC at 760 mmHg
Melting point: 44ºC
Flash point: 110.3ºC

 
Applications: Phenylthio-based reagents can be added to unsaturated compounds to prepare optically active compounds.

Items of Analysis Standard of Analysis Test Results
Appearance Dark red liquid Conforms
Assay ≥98.0% 99.21%
Conclusion Conforms to Factory Standard
 




Contact us for information like phenyl thiohypochlorite chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Phenylsulfenylchloride physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Phenyl-sulfoniumylidene Chloride Use and application,Phenyl-sulfoniumylidene Chloride technical grade,usp/ep/jp grade.


Related News: ll coronaviruses are zoonotic, meaning they are transmitted between animals and people.diethyl 2-aminoindolizine-1,3-dicarboxylate manufacturer As a result, the Company’s platform is uniquely capable of overcoming numerous limitations associated with the production of cell therapies using patient- or donor-sourced cells, which is logistically complex and expensive and is subject to batch-to-batch and cell-to-cell variability that can affect clinical safety and efficacy.N,N-Diphenyl-acetamide; compound with GENERIC INORGANIC NEUTRAL COMPONENT supplier The mode of cooperation between domestic API companies and large international companies can lower the export threshold.5-Acetyl-2,4-dimethylthiazole vendor An analysis of the top 20 global companies by R&D spend for 2018 shows that companies with expensive late-stage pipeline drugs are spending significant proportions of their annual revenue on R&D.ViiV, in which Pfizer and Shionogi have small stakes, said it received a so-called complete response letter (CRL) from the FDA in which the regulator questioned the treatment’s chemistry, manufacturing and controls process, but not its safety.